San Francisco, CA, United States of America

Alina He

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Abbvie Stemcentrx LLC. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alina He. Retrieved from https://idiyas.com/inventor/alina-he-w2fv268j

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alina He: Innovator in Cancer Treatment

Introduction

Alina He is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of cancer treatment through her innovative research and development of novel antibodies.

Latest Patents

Alina He holds a patent for "Anti-BMPR1B antibodies and methods of use." This patent includes novel anti-BMPR1B antibodies and antibody drug conjugates, along with methods for utilizing these antibodies to treat cancer. Her work represents a significant advancement in therapeutic options for patients.

Career Highlights

Alina is currently employed at AbbVie Stemcentrx LLC, where she continues to focus on groundbreaking research in oncology. Her dedication to improving cancer treatments has positioned her as a key figure in the industry.

Collaborations

Alina collaborates with talented professionals, including Somdutta Roy and Laura Saunders, who contribute to her research efforts and enhance the impact of her work.

Conclusion

Alina He is a remarkable inventor whose work in developing anti-BMPR1B antibodies is paving the way for new cancer therapies. Her contributions to the field are invaluable and highlight the importance of innovation in medical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…